U.S., Nov. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07226050) titled 'CLF065 for Chronic Pouchitis' on Nov. 06.
Brief Summary: This clinical trial is to evaluate investigational compound CLF065 as a treatment for adult patients with chronic pouchitis. The goals are to establish the safety, feasibility and efficacy of weekly dosing of long acting CLF065 versus placebo.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Pouchitis
Intervention:
DRUG: CLF065
will receive investigational product every week for 13 weeks as a sub-cutaneous injection
DRUG: Placebo
CLF065 matching placebo
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Calibr, a division of Scripps Research
Disclaim...